Medicago awarded $21 million from the U.S. Department of Defense
Medicago to develop a vaccine facility in Research Triangle Park, North Carolina
12-Aug-2010 -
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., announced that it has been awarded a $21 Million grant from the Defense Advanced Research Projects Agency (DARPA), Broad Agency Announcement (BAA), Defense Sciences Research & Technology to demonstrate the scalable manufacturing of ...
Medicago
pandemic influenza
scale-up
+1